Evidence map›Paper›PMID 40830998›Full record

ArticleJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society2024

ChatGPT Assisting Diagnosis of Neuro-Ophthalmology Diseases Based on Case Reports.

Yeganeh Madadi, Mohammad Delsoz, Priscilla A Lao, Joseph W Fong, T J Hollingsworth, Malik Y Kahook, Siamak Yousefi

Abstract read
In one paragraph

Article in Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Large Language Models in Neurological Practice: Real-World Study.Journal of medical Internet research · 2025
    Article
  10. Article
  11. Article
  12. Reply: Diagnosing Neuro-Ophthalmology Diseases Based on Case Reports: DeepSeek vs ChatGPT.Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Yeganeh MadadiDepartment of Ophthalmology (YM, MD, PAL, JWF, TJH, SY), University of Tennessee Health Science Center, Memphis, Tennessee; Department of Ophthalmology (MYK), University of Colorado School of Medicine, Aurora, Colorado; and Department of Genetics, Genomics, and Informatics (SY), University of Tennessee Health Science Center, Memphis, Tennessee.ORCID 0000-0003-4292-3404
T J HollingsworthORCID 0000-0002-2119-521
Malik Y Kahook

Funding

Predicting the risk of glaucoma from structural, functional, and genetic factors using artificial intelligenceR01EY033005 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI YOUSEFI, SIAMAK · 2022 to 2025
$2.4M
National Institutes of Health (NIH) R01EY033005NEI NIH HHS R01 EY033005
6 · The paper itself

Abstract

backgroundTo evaluate the accuracy of Chat Generative Pre-Trained Transformer (ChatGPT), a large language model (LLM), to assist in diagnosing neuro-ophthalmic diseases based on case reports.

methodsWe selected 22 different case reports of neuro-ophthalmic disorders from a publicly available online database. These cases included a wide range of chronic and acute diseases commonly seen by neuro-ophthalmologists. We inserted each case as a new prompt into ChatGPTs (GPT-3.5 and GPT-4) and asked for the most likely diagnosis. We then presented the exact information to 2 neuro-ophthalmologists and recorded their diagnoses, followed by comparing responses from both versions of ChatGPT.

resultsGPT-3.5 and GPT-4 and the 2 neuro-ophthalmologists were correct in 13 (59%), 18 (82%), 19 (86%), and 19 (86%) out of 22 cases, respectively. The agreements between the various diagnostic sources were as follows: GPT-3.5 and GPT-4, 13 (59%); GPT-3.5 and the first neuro-ophthalmologist, 12 (55%); GPT-3.5 and the second neuro-ophthalmologist, 12 (55%); GPT-4 and the first neuro-ophthalmologist, 17 (77%); GPT-4 and the second neuro-ophthalmologist, 16 (73%); and first and second neuro-ophthalmologists 17 (77%).

conclusionsThe accuracy of GPT-3.5 and GPT-4 in diagnosing patients with neuro-ophthalmic disorders was 59% and 82%, respectively. With further development, GPT-4 may have the potential to be used in clinical care settings to assist clinicians in providing accurate diagnoses. The applicability of using LLMs like ChatGPT in clinical settings that lack access to subspeciality trained neuro-ophthalmologists deserves further research.

Indexed as

Eye DiseasesNervous System DiseasesFemaleGenerative Artificial IntelligenceHumansMaleNeurologyOphthalmology

Identifiers

PMID40830998
PMCPMC12341750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.